SBIR-TT RFP: Transcatheter Cerclage Mitral Valve Annuloplasty

The National Heart, Lung, and Blood Institute (NHLBI) invites small business concerns to submit research proposals for the development of commercial-grade interventional tools to make a clinical annuloplasty procedure for the treatment of secondary mitral valve regurgitation simple and safe, including device and regulatory development, followed by early clinical testing.  

This is an SBIR Technology Transfer contract topic from the NHLBI. This is a new program whereby inventions from the NHLBI Division of Intramural Research are licensed to qualified small businesses with the intent that those businesses develop these inventions into commercial products that benefit the public. The contractor funded under this NHLBI SBIR contract topic can work in a collaborative manner with the NHLBI Inventor(s) regarding catheter designs, procedure techniques, clinical considerations, and discussions during the entire award period.  

View the solicitation.

Pre-submission Meeting for Applicants

A pre-submission meeting was held on June 14th, 2012. NHLBI staff explained the objectives of the solicitation, described the applicable NIH technology, and answered questions related to licensing and the acquisitions process. View a recording of the webinar.

Frequently Asked Questions

Questions and Answers from the pre-submission meeting are now available with the solicitation.   If you have additional questions, they should be emailed to bursieyl@nhlbi.nih.gov